TwinBeech Capital’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding GLUE
BBA
TwinBeech Capital's GLUE Position: Q3 2026 in Review
TwinBeech Capital opened a new position in Monte Rosa Therapeutics (GLUE) in Q3 2026: 29,535 shares worth $352K. The stake represents 0.08% of the portfolio and ranks #272 among its holdings.
190 funds tracked by Wall St. Rank hold GLUE as of Q3 2026.
- TwinBeech Capital held 29,535 shares of Monte Rosa Therapeutics worth $352K as of Q3 2026.
- Monte Rosa Therapeutics was a new TwinBeech Capital position in Q3 2026.
- Monte Rosa Therapeutics made up 0.08% of TwinBeech Capital's portfolio in Q3 2026, its #272 holding.
- 190 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.